As healthcare challenges continue to grow, so does the need for innovative ways to meet them. Observe Medical develops medtech solutions that help ensure healthcare professionals and patients benefit from the highest standards of care safely and cost-effectively.
Oslo, February 23[rd], 2020 – Observe Medical ASA (OSE: OBSRV) today released its presentation of the fourth quarter 2020, reporting continued progress in terms of the commercialization and go-to-market strategy for its first product Sippi®. Sippi® is a unique and proprietary solution for digital automated urine monitoring in hospitals. “Sippi® contributes to improved clinical outcome…
Read moreOslo February 22, 2021 – Observe Medical ASA (OSE: OBSERV), announces that Nya Karolinska Sjukhuset in Stockholm, Sweden resumes the implementation of Sippi® in clinical use at the Cardiothoracic ICU unit following a pause during 2020, due to Covid-19 As a result of the recent improvements of the Covid-19 situation at the hospital, the…
Read moreObserve Medical ASA invites you to a presentation of the fourth quarter 2020 on Tuesday February 23 at 8.30 CET. Due to the covid-19 situation the presentation will only be held as a webcast. The event will start at 08.30 CET and will be webcasted on www.observemedical.com – Investor relations and on the following link: https://channel.royalcast.com/landingpage/hegnarmedia/20210223_2/…
Read moreObserve Medical is a Nordic based medtech developer with development, quality, regulatory and commercial operations in Gothenburg, Sweden, and headquarters in Oslo, Norway.
The prevalence and cost of hospital acquired infection are growing challenges for healthcare facilities. Sippi infection inhibiting automated digital urine meter system from Observe Medical can help.